Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.

ABSTRACT: Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within 3 years of CD diagnosis. Thus, meningococcal vaccination rates among patients with CDs need to be improved.

SUBMITTER: Marshall GS 

PROVIDER: S-EPMC9402647 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature